Topic summary
Priority review voucher
Extracted from the Wikipedia article Priority review.
External links
- Priority review voucher page published by one of the Duke authors of the voucher
- "FDA to aid tropical disease research" at the Financial Times in 2008
- Optional Rewards for New Drugs for Developing Countries, a critique from the WHO's Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH)
- SEC. 524. (21 USC §360n) Text of the amendment
- Rare Pediatric Disease Priority Review Vouchers from the U.S. Food and Drug Administration (FDA), 2019